During the past decade, Columbia Arthritis Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 17 clinical trials were completed, i.e. on average, 141.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 13 clinical trials were completed. i.e. 325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia Arthritis Center" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Arthritis Center" #1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Columbia Arthritis Center" are "Rheumatoid Arthritis" (7 trials), "Arthritis, Rheumatoid" (2 trials), "Axial Spondyloarthritis" (2 trials), "Low Back Pain" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "Columbia Arthritis Center" in a lesser frequency.

Most popular intervention types in "Columbia Arthritis Center" are "Drug" (24 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ixekizumab" (4 trials), "Adalimumab" (3 trials), "Filgotinib" (3 trials) and "Placebo to match filgotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Columbia Arthritis Center" are 23 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Columbia Arthritis Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Columbia Arthritis Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia Arthritis Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".